Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa
Natura:	Artigo
Lingua:	inglese
Pubblicazione:	2001
Accesso online:	https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
di: Ryutaro Oba, et al.
Pubblicazione: (2005)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
di: Zou, Kun, et al.
Pubblicazione: (2007)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
di: Assarsson, Anna, et al.
Pubblicazione: (2014)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
di: Anna Assarsson, et al.
Pubblicazione: (2014)

New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
di: Yuji Yoshiike, et al.
Pubblicazione: (2001)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ<sub>1–42</sub>) to Aβ<sub>1–40</sub>, and Its Inhibition Enhances Brain Aβ Deposition
di: Kun Zou, et al.
Pubblicazione: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
di: Wisniewski, Thomas, et al.
Pubblicazione: (2008)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
di: Abelein, Axel, et al.
Pubblicazione: (2015)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
di: Axel Abelein, et al.
Pubblicazione: (2015)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
di: Joshi, P, et al.
Pubblicazione: (2014)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
di: P. Joshi, et al.
Pubblicazione: (2013)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
di: Zou, Kun, et al.
Pubblicazione: (2009)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
di: Kun Zou, et al.
Pubblicazione: (2009)

TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity
di: Fan, Yujuan, et al.
Pubblicazione: (2017)

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
di: Elizabeth A. Eckman, et al.
Pubblicazione: (2006)

The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
di: Kimberly Boland, et al.
Pubblicazione: (1996)

TDP-43 expression influences amyloid β plaque deposition and tau aggregation
di: Davis, Stephani A., et al.
Pubblicazione: (2017)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
di: Stephani A. Davis, et al.
Pubblicazione: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
di: Korshavn, Kyle J., et al.
Pubblicazione: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
di: Kyle J. Korshavn, et al.
Pubblicazione: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
di: Garai, Kanchan, et al.
Pubblicazione: (2014)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
di: Kanchan Garai, et al.
Pubblicazione: (2014)

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme
di: Shuyu Liu, et al.
Pubblicazione: (2014)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
di: Du, Wen-Jie, et al.
Pubblicazione: (2015)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
di: Wenjie Du, et al.
Pubblicazione: (2015)

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
di: Mikhail Matveyenka, et al.
Pubblicazione: (2025)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
di: Wang, Qiuming, et al.
Pubblicazione: (2013)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
di: Qiuming Wang, et al.
Pubblicazione: (2013)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
di: Hemming, Matthew L., et al.
Pubblicazione: (2005)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
di: Larmuth, Kate M., et al.
Pubblicazione: (2016)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
di: Matthew L. Hemming, et al.
Pubblicazione: (2005)

A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition
di: Hou, Li‐Na, et al.
Pubblicazione: (2013)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
di: Jin, Sha, et al.
Pubblicazione: (2016)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
di: Sha Jin, et al.
Pubblicazione: (2016)

β‐Amyloid aggregation and heterogeneous nucleation
di: Srivastava, Atul K., et al.
Pubblicazione: (2019)

β‐Amyloid aggregation and heterogeneous nucleation
di: Atul Srivastava, et al.
Pubblicazione: (2019)

Aggregation and structure of amyloid β-protein
di: Kenjiro Ono, et al.
Pubblicazione: (2021)

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
di: Takami Tomiyama, et al.
Pubblicazione: (1996)

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity
di: Wang, Peng, et al.
Pubblicazione: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
di: Kehoe, Patrick Gavin, et al.
Pubblicazione: (2016)